NDC 0019-1323

Optiray 320

Ioversol

Optiray 320 is a Intra-arterial; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Liebel-flarsheim Company Llc. The primary component is Ioversol.

Product ID0019-1323_0d687753-5c3f-47b3-921e-4c2f22ba6717
NDC0019-1323
Product TypeHuman Prescription Drug
Proprietary NameOptiray 320
Generic NameIoversol
Dosage FormInjection
Route of AdministrationINTRA-ARTERIAL; INTRAVENOUS
Marketing Start Date2012-03-04
Marketing CategoryNDA / NDA
Application NumberNDA019710
Labeler NameLiebel-Flarsheim Company LLC
Substance NameIOVERSOL
Active Ingredient Strength678 mg/mL
Pharm ClassesRadiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0019-1323-00

20 SYRINGE, PLASTIC in 1 CARTON (0019-1323-00) > 100 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2012-03-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0019-1323-61 [00019132361]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA020923
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2011-10-17

NDC 0019-1323-83 [00019132383]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-02 [00019132302]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-16 [00019132316]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-85 [00019132385]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-81 [00019132381]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-77 [00019132377]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-78 [00019132378]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-90 [00019132390]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-75 [00019132375]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-11 [00019132311]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-91 [00019132391]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-27 [00019132327]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-52 [00019132352]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-00 [00019132300]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-95 [00019132395]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-70 [00019132370]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-41 [00019132341]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04
Marketing End Date2016-03-07

NDC 0019-1323-87 [00019132387]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-55 [00019132355]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-03-04

NDC 0019-1323-73 [00019132373]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-04 [00019132304]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-21 [00019132321]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

NDC 0019-1323-06 [00019132306]

Optiray 320 INJECTION
Marketing CategoryNDA
Application NumberNDA019710
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-03-04

Drug Details

Active Ingredients

IngredientStrength
IOVERSOL678 mg/mL

OpenFDA Data

SPL SET ID:6cb6ca5f-b249-49b0-a9eb-8aa583da7c74
Manufacturer
UNII
UPC Code
  • 0300191323613
  • 0300191333612
  • 0300191332615
  • Pharmacological Class

    • Radiographic Contrast Agent [EPC]
    • X-Ray Contrast Activity [MoA]

    NDC Crossover Matching brand name "Optiray 320" or generic name "Ioversol"

    NDCBrand NameGeneric Name
    0019-1323OptirayIoversol
    0019-1324OptirayIoversol
    0019-1332OptirayIoversol
    0019-1333OptirayIoversol

    Trademark Results [Optiray]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    OPTIRAY
    OPTIRAY
    73710159 1526467 Live/Registered
    MALLINCKRODT, INC.
    1988-02-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.